Neoadjuvant Chemoradiation Plus PD-1 Antibody(SHR-1210) in Locally Advanced Proximal Stomach Adenocarcinoma

NCT03631615 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma

Interventions

DRUG: Neoadjuvant chemoradiation plus PD-1 antibody(SHR-1210)

Sponsor

Shanghai Zhongshan Hospital

Collaborators

[object Object]